KPMG’s newest report on leading Life Sciences Clusters in Europe reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.
What makes a European Life Science site attractive to foreign investors? KPMG Switzerland has released its 2016 Report on “Site Selection for Life Sciences Companies in Europe”, which offers important background information for international LS companies looking to expand, restructure or consolidate their activities in Europe and for investors interested in European Life Sciences. The report compares European countries with strong LS industries in terms of size and strength of their LS clusters and their attractiveness to Foreign Direct Investments.
© 2016 KPMG Holding AG is a member of the KPMG network of independent firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss legal entity. All rights reserved.